Filing Flows › Boston Scientific (BSX) › Q1 2026
Boston Scientific (BSX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 1, 2026
Boston Scientific (BSX) reported revenue of $5.2B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -2% from the quarter before. Operating margin was 21.2%, net earnings $1.3B (25.7% of revenue).
Boston Scientific, Q1 2026: revenue $5.2B (+12% year over year), operating margin 21.2%, net earnings $1.3B, operating cash flow $348M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2B | -2% | +12% |
| Gross profit | $3.6B | -2% | +13% |
| Operating profit | $1.1B | +33% | +20% |
| Net earnings | $1.3B | +100% | +99% |
| Operating cash flow | $348M | -74% | -36% |
| Free cash flow | $171M | -83% | -52% |
What changed
Revenue was $5.2B in Q1 2026, up 12% year over year and down 2% from the previous quarter. Interventional Cardiology & Vascular Therapies was the largest line at 24% of revenue. Electrophysiology added $0.17B year over year (up 24%), 32% of the total change.
Gross margin was 69.5%, up 0.6 points from Q1 2025. Operating profit was $1.1B, a 21.2% margin (up 1.4 points year over year). Of the extra revenue versus Q1 2025, 33% reached operating profit, above the 20% margin then. Operating expenses grew 10% against revenue growth of 12%. The fastest-growing cost line was Research & development (+16%). Net earnings were $1.3B, up 99% year over year. The effective tax rate was -15.1%.
Operating cash flow was $0.35B (down 36% year over year), 26% of net earnings. Non-cash charges added back $0.35B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $1.4B. Capital expenditures of $0.18B left free cash flow of $0.17B.
Questions
What was Boston Scientific's revenue in the first quarter 2026?
Boston Scientific (BSX) reported revenue of $5.2B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -2% from the quarter before.
Was Boston Scientific profitable in the first quarter 2026?
Operating profit was $1.1B (21.2% of revenue) and net earnings $1.3B.
Source: Boston Scientific 10-Q on SEC EDGAR.